Expression of a calmodulin inhibitor peptide in progenitor alveolar type II cells disrupts lung development

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 271, Issue 2 15-2, 1996, Pages

  Wang, Jiahong ^a   Campos, Begoña ^a   Kaetzel, Marcia A ^a   Dedman, John R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

dominant negative; targeted gene expression; transgenic mice

Indexed keywords

CALMODULIN INHIBITOR; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL GROWTH; GENE EXPRESSION REGULATION; LUNG ALVEOLUS CELL TYPE 2; LUNG DEVELOPMENT; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

EID: 0029845364     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.271.2.l245     Document Type: Article

References (24)

1. Blumenthal, D. K., H. Charbonneau, A. M. Edelman, T. R. Hinds, G. B. Rosenberg, D. R. Storm, F. F. Vincenzi, J. A. Beavo, and E. D. Krebs. Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of the other calmodulin-dependent enzymes. Biochem. Biophys. Res. Commun. 156: 860-865, 1988.
2. Brinster, R. L., J. M. Allen, R. P. Behringer, R. E. Gelinas, and R. D. Palmiter. Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA 85: 836-840, 1988.
3. Campbell, A. K. Intracellular Calcium: Its Universal Role as Regulator. New York: Wiley, 1983.
4. Davis, T. N., M. S. Urdea, F. R. Masiarz, and J. Thorner. Isolation of the yeast calmodulin gene: calmodulin is an essential protein. Cell 47: 423-431, 1986.
5. 2+-transport ATPase and brain phosphodiesterase by activators and inhibitors. Biochem. J. 207: 541-548, 1982.
6. Glasser, S. W., T. R. Korfhagen, S. E. Wert, M. D. Bruno, K. M. McWilliams, D. K. Vorbroker, and J. A. Whitsett. Genetic element from human surfactant protein SPC gene confers bronchiolar-alveolar cell specificity in transgenic mice. Am. J. Physiol. 261 (Lung Cell. Mol. Physiol. 5): L349-L356, 1991.
7. Glasser, S. W., T. R. Korfhagen, S. E. Wert, and J. A. Whitsett. Transgenic models for study of pulmonary development and disease. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11): L489-L497, 1994.
8. Inagaki, M., S. Kawamoto, H. Itoh, M. Hagiwara, J. Takahashi, and H. Hidaka. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors. Mol. Pharmacol. 29: 577-581, 1986.
9. 2+/calmodulin-dependent cyclic nucleotide phosphodiesterase. J. Biochem. 96: 1721-1726, 1984.
10. Korfhagen, T. R., R. J. Swantz, S. E. Wert, J. M. McCarty, C. B. Keriakian, S. W. Glasser, and J. A. Whitsett. Respiratory epithelial cell expression of human transforming growth factor-α induces lung fibrosis in transgenic mice. J. Clin. Invest. 93: 1691-1699, 1994.
11. Korfhagen, T. R., S. W. Glasser, S. E. Wert, M. D. Bruno, C. C. Daugherty, J. D. McNeish, J. L. Stock, S. S. Potter, and J. A. Whitsett. Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 87: 6122-6126, 1990.
12. Levin, R. M., and B. Weiss. Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins. Biochim. Biophys. Acta 540: 197-204, 1978.
13. Lyon, M. F. Gene activation in the X-chromosome of the mouse. Nature Lond. 190: 372-373, 1961.
14. Peters, K., S. Werner, X. Liao, S. Wert, and J. A. Whitsett. Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO J. 13: 3296-3301, 1994.
15. 1 and mitosis. EMBO J. 8: 73-82, 1989.
16. Rasmussen, C. D., R. L. Means, K. P. Lu, G. S. May, and A. R. Means. Characterization and expression of the unique calmodulin gene of Aspergillus nidulans. J. Biol. Chem. 265: 13767-13775, 1990.
17. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982.
18. Schatzman, R. C., B. C. Wise, and J. F. Kuo. Phospholipid-sensitive calcium-dependent protein kinase: inhibition by anti-psychotic drugs. Biochem. Biophys. Res. Commun. 98: 669-676, 1981.
19. Singh, G., S. L. Katyal, W. E. Brown, S. Phillips, A. L. Anthony, and N. Squeglia. Amino-acid and cDNA nucleotide sequence of human Clara cell 10 kDa protein. Biochim. Biophys. Acta 950:329-337, 1988.
20. Takeda, T., and M. Yamamoto. Analysis and in vivo disruption of the gene coding for calmodulin in Schizosaecharmyees pombe. Proc. Natl. Acad. Sci. USA 84: 3580-3584, 1987.
21. Ten Have-Opbroek, A. A. W. The development of the lung in mammals: an analysis of concept and findings. Am. J. Anat. 162: 201-219, 1981.
22. Veigl, M., R. E. Klevit, and W. D. Sedwick. The uses and limitations of calmodulin antagonists. Pharmacol. Ther. 44: 181-193, 1989.
23. Wang, J., B. Campos, G. A. Jamieson, Jr., M. A. Kaetzel, and J. R. Dedman. Functional elimination of calmodulin within the nucleus by targeted expression of an inhibitor peptide. J. Biol. Chem. 270: 30245-30248, 1995.
24. Wert, S. E., S. W. Glasser, T. R. Korfhagen, and J. A. Whitsett. Transcriptional elements from the human SPC gene direct expression in the primordial respiratory epithelium of transgenic mice. Dev. Biol. 156: 426-443, 1993.